Salute e Benessere

Bioanalytical Testing Services Market: Rising Demand for Precision Drives 15%…

WuXi AppTec's laboratory testing department has increased productivity by 400% since its early start in implementing bioanalytical automation. The bioanalytical testing services market includes CROs and other providers of bioanalytical testing services to the pharma and biotech industries. WuXi AppTec's laboratory testing department has increased productivity by 400% since its early start in implementing bioanalytical automation. The bioanalytical testing services market includes CROs and…
PR Newswire
17/07/2024

Cancer/Tumor Profiling Market to be Worth $24.70 Billion by 2031 - Exclusive…

Cancer/tumor profiling is widely conducted in clinical and research settings. The growth of this market is driven by factors such as the increasing prevalence of cancer, the rising pharmaceutical R&D expenditures, the growing number of targeted therapies and the discovery of new actionable biomarkers, increasing investments in cancer research, the declining costs of NGS-based profiling, and advancements in multi-omics tumor profiling. However, the high capital investments required for NGS…
PR Newswire
17/07/2024

AI-Based Medical Diagnostic Tools Market Set to Exceed USD 11.5 Billion by 2034…

In addition to enhancing the efficiency of existing algorithms, this involves investigating new artificial intelligence approaches such as deep learning, reinforcement learning, and federated learning for medical applications. In addition to enhancing the efficiency of existing algorithms, this involves investigating new artificial intelligence approaches such as deep learning, reinforcement learning, and federated learning for medical applications. AI-based diagnostic tools can empower...
PR Newswire
17/07/2024

Bon Secours Mercy Health and Philips sign multi-year strategic collaboration

Patient monitoring platform to deliver tools and time to help patients across 40+ care sitesAmsterdam, the Netherlands, and Cincinnati, Ohio – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation's largest Catholic health systems, today announced a multi-year strategic collaboration for patient monitoring. Putting BSMH clinicians in control, the collaboration will reduce the digital burden on staff and...
Nasdaq GlobeNewswire
17/07/2024

Hemostasis Products Market to Reach USD 4.5 Billion by 2034, Driven by a 5.7%…

With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected to increase, which will likely drive the global landscape. The rising number of chronic diseases is expected to fuel the demand for surgical interventions. With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected…
PR Newswire
17/07/2024

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024

Company Announcement Net sales of DARZALEX ®in the second quarter of 2024 totaled USD 2,878 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; July 17, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ®(daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj , sold under the tradename DARZALEXFASPRO®...
Nasdaq GlobeNewswire
17/07/2024

Drugs of Abuse Testing Market Fueled by Rise in Drug Abuse Cases: 13.5% CAGR to…

Specific policies for drug abuse testing may differ throughout organizations and environments. For instance, the Department of Health and Human Services (DHHS) has mandatory occupational urine testing criteria that normally include testing for five substances of abuse: amphetamines, cannabis, cocaine, opiates, and PCP. However, other drugs might also be checked for depending on the particulars. Specific policies for drug abuse testing may differ throughout organizations and environments...
PR Newswire
17/07/2024

Grünenthal announces significant investments in its Latin America production…

"Our investment in Latin America is a strong demonstration of our commitment to long-term competitiveness in the region," says Victor Barbosa, Head of Global Operations and member of the Executive Board Team. "Future-proofing our manufacturing capabilities underscores our commitment to ensuring a safe, reliable, and efficient supply of medicine to patients globally. Grünenthal delivers high-quality medicine from Latin America to the world—a unique capability in the region."…
PR Newswire
17/07/2024

Drug Repurposing Market Projected to Reach USD 47.8 Billion by 2034 with a CAGR…

This change in the size of the industry is attributed to a sluggish development of the sector. With several opportunities created for key players in the sector, the ecosystem is set to progress at a CAGR of 4.7% through 2034. This change in the size of the industry is attributed to a sluggish development of the sector. With several opportunities created for key players in the sector, the ecosystem is set to progress at a CAGR of 4.7% through 2034. With the elevated drug development...
PR Newswire
17/07/2024

Cholesterol Testing Products Market Worth US$ 49.4 Billion by 2034 | Exclusive…

With the growing proportion of obese population across the world, the rate of heart issues is growing. People have been struggling to ensure the well-being of the heart, which drives the demand for suitable measures to arrest such issues. With the growing proportion of obese population across the world, the rate of heart issues is growing. People have been struggling to ensure the well-being of the heart, which drives the demand for suitable measures to arrest such issues. The demand from...
PR Newswire
17/07/2024

Future of Central Nervous System Therapeutics Market Worth USD 231.8 Billion by…

The progress of the competitive landscape will help the market valuation reach USD 231.8 billion by 2034. The last recorded size of the industry was USD 102.4 billion in 2023. The progress of the competitive landscape will help the market valuation reach USD 231.8 billion by 2034. The last recorded size of the industry was USD 102.4 billion in 2023. The likelihood of various neurological disorders is growing with the rising senior population across the world. Along with this, many...
PR Newswire
17/07/2024

BioProcess360 Partners launch dedicated Life Sciences investment fund to grow…

Will connect innovators with investment, hands-on expertise and the leading biopharmaceutical manufacturers “The largest challenges businesses face when establishing new technologies in the bioprocessing space typically stem from a lack of access to real industry experience and knowledge required to help them navigate through critical growth challenges. Being a serial entrepreneur, I know exactly what it takes to be truly successful in this space” said Chris Major, Founding Partner,...
Nasdaq GlobeNewswire
17/07/2024

First procedure in Netherlands with NaoTrac surgical navigation robot is…

To avoid long and frustrating registration process, NaoTrac incorporates machine vision technology, and finishes the patient and instrument registrations within 30 seconds to 3 minutes. It is an open platform, and the instrument registration is performed by the robotic arm automatically, much safer and faster. To avoid long and frustrating registration process, NaoTrac incorporates machine vision technology, and finishes the patient and instrument registrations within 30 seconds to 3 minutes...
PR Newswire
17/07/2024

De Motu Cordis (DMC) announces plans for the next stage of development for…

"We are excited to build on our partnership with Catalent, one of the world's leading CDMOs, and look forward to Catalent's team supporting our ability to further advance DMC-IH1, through support for drug product manufacture and dry powder inhaler assembly," said Peter O'Neill, Chief Executive Officer, DMC. "Catalent provides DMC with a consistency of quality and manufacturing excellence in the United States to service global markets." "We are excited to build on our…
PR Newswire
17/07/2024

Orexo Q2 2024 Interim Report

Q2 2024 highlights Q2 2024 highlights Important events after the end of the ­period CEO comments in brief: Strong Zubsolv® recovery and focus on getting OX124 to the US market"I am pleased to report our Zubsolv sales grew slightly year on year, with a strong improvement from the first quarter. This is the third consecutive quarter that we have achieved a positive EBITDA, despite additional costs for a new human factor study (HF study) for OX124, increased legal expenses and a...
PR Newswire
17/07/2024

EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg…

EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg Engineering and continues to make moves in the med-tech spaceThe transaction will create growth opportunities for Heidelberg Engineering and confirms EssilorLuxottica's commitment to further elevating industry standards and enhancing patients' quality careParis, France and Heidelberg, Germany (17 July 2024 – 8 am CEST) – EssilorLuxottica and Heidelberg Engineering announced today they entered into an...
Nasdaq GlobeNewswire
17/07/2024

EssilorLuxottica to Acquire Supreme® from VF Corporation

EssilorLuxottica to AcquireSupreme®from VF Corporation Paris, France and Denver, CO (17 July 2024 – 8am CEST) -EssilorLuxottica, a global leader in the optical industry, and VF Corporation (NYSE: VFC), a global leader in branded lifestyle apparel, footwear and accessories, today announced that they have entered into a definitive agreement for EssilorLuxottica to acquire theSupreme ® brand from VF for $1.5 billion in cash. Francesco Milleri, Chairman and Chief...
Nasdaq GlobeNewswire
17/07/2024

ONWARD® Medical Publishes Annual Sustainability Summary

Company strengthens sustainability practices prior to commercialization hereand on the Company's website in the Investors section ( https://ir.onwd.com/esg-information ). EcoVadis, the world's largest provider of business sustainability ratings, rated ONWARD Medical in the top 40% in the industry for its sustainability performance. The EcoVadis assessment evaluates 20+ sustainability criteria across four core themes: Environment, Labor & Human Rights, Ethics, and Sustainable...
Nasdaq GlobeNewswire
17/07/2024

Inside information: Phase III ARANOTE trial of darolutamide in combination with…

ORION CORPORATIONSTOCK EXCHANGE RELEASE – INSIDE INFORMATION 17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpoint Orion and Bayer's Phase III ARANOTE trial meets primary endpoint, significantly increasing radiological progression-free survival (rPFS) with darolutamide + androgen deprivation therapy (ADT) compared to...
Nasdaq GlobeNewswire
17/07/2024

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I…

After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p < 0.001) 1 Pharmacokinetic data supports a once-daily oral dosing regimen for CT-996 1 The safety and tolerability profile was consistent with other oral GLP-1 receptor agonists and no unexpected safety signals were observed 1 Basel, 17 July 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive topline results from two arms of an ongoing...
Nasdaq GlobeNewswire
17/07/2024

Orexo shares new information on OX124, a high-dose naloxone rescue medication in…

The type of technical data required by FDA has already been generated from our pilot scale manufacturing and the data were included in the NDA. Orexo´s assessment is that the submitted data support approval however, FDA does not agree and has requested data from the established commercial scale manufacturing. The type of technical data required by FDA has already been generated from our pilot scale manufacturing and the data were included in the NDA. Orexo´s assessment is that the submitted...
PR Newswire
16/07/2024

Contact and Intraocular Lens Market Expected to Reach US$ 22.9 Billion by 2034…

This development of the industry will likely project the advancement path at a moderate CAGR of 6.4% through the forecasted period. Influenced by various driving forces, the market will create lucrative prospects for key players. The growing prevalence related to eyesight issues and cataracts has leveraged the demand for contact lenses. With the elevated demand for treatments for eyesight correction, leading manufacturers can expect better prospects in the forecasted period. In the...
PR Newswire
16/07/2024

Corneal Transplant Market to Reach an Estimated US$ 805.8 Million by 2034 with a…

Innovations in corneal transplant procedures, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Endothelial Keratoplasty (DSEK), have improved outcomes and reduced recovery times, making these surgeries more attractive to patients and practitioners. Innovations in corneal transplant procedures, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Endothelial Keratoplasty (DSEK), have improved outcomes and reduced recovery…
PR Newswire
16/07/2024

Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug…

In this free webinar, the expert speakers will provide an introduction to free selection on different target types ranging from enzymes to receptors and highlight the unique advantages or features for the application of DELs on these targets. They will also describe various DEL platforms that have been developed and how they can be utilized to achieve success in the drug discovery process. In this free webinar, the expert speakers will provide an introduction to free selection on different...
PR Newswire
16/07/2024
Altri  Comunicati